A detailed history of Point72 (Difc) LTD transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 381 shares of HOWL stock, worth $605. This represents 0.0% of its overall portfolio holdings.

Number of Shares
381
Previous 14,046 97.29%
Holding current value
$605
Previous $34.3 Million 97.64%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.71 - $2.95 $23,367 - $40,311
-13,665 Reduced 97.29%
381 $808,000
Q2 2024

Aug 14, 2024

BUY
$2.34 - $6.75 $32,867 - $94,810
14,046 New
14,046 $34.3 Million

Others Institutions Holding HOWL

About Werewolf Therapeutics, Inc.


  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $47M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.